Tetralogic Pharmaceuticals Corp Now Covered by Guggenheim (TLOG)
Investment analysts at Guggenheim started coverage on shares of Tetralogic Pharmaceuticals Corp (NASDAQ:TLOG) in a note issued to investors on Monday, American Banking News reports. The firm set a “buy” rating and a $15.00 price target on the stock. Guggenheim’s price target would suggest a potential upside of 43.13% from the company’s current price.
Tetralogic Pharmaceuticals Corp (NASDAQ:TLOG) opened at 10.48 on Monday. Tetralogic Pharmaceuticals Corp has a 1-year low of $6.91 and a 1-year high of $10.97. The stock’s 50-day moving average is $8.1 and its 200-day moving average is $8.1. The company’s market cap is $135.1 million.
TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) is a clinical-stage biopharmaceutical company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.